Pediatricians and antidepressant medications: black box or black hole?
Wegner
Lynn Mowbray
LM
Learning and Development Associates, 3500 Gateway Centre Blvd, Suite 140, Morrisville, NC 27560, USA. lwegner@learningfirst.com
D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research; D002648:Child; D002662:Child Health Services; D017277:Drug Approval; D004502:Education, Medical, Continuing; D006801:Humans; D007400:Interprofessional Relations; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy*; D008605:Mental Health Services; D010372:Pediatrics / Q000193:education; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D013405:Suicide; D014481:United States; D014486:United States Food and Drug Administration
D000928:Antidepressive Agents